Wave Life Sciences Ltd.
WVE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $108,302 | $113,305 | $3,649 | $40,964 |
| % Growth | -4.4% | 3,005.1% | -91.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $108,302 | $113,305 | $3,649 | $40,964 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $159,682 | $130,009 | $115,856 | $121,875 |
| G&A Expenses | $59,023 | $51,292 | $50,513 | $46,105 |
| SG&A Expenses | $59,023 | $51,292 | $50,513 | $46,105 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $218,705 | $181,301 | $166,369 | $167,980 |
| Operating Income | -$110,403 | -$67,996 | -$162,720 | -$127,016 |
| % Margin | -101.9% | -60% | -4,459.3% | -310.1% |
| Other Income/Exp. Net | $13,395 | $9,806 | $1,578 | $4,567 |
| Pre-Tax Income | -$97,008 | -$58,190 | -$161,142 | -$122,449 |
| Tax Expense | $0 | -$677 | $681 | -$204 |
| Net Income | -$97,008 | -$57,513 | -$161,823 | -$122,245 |
| % Margin | -89.6% | -50.8% | -4,434.7% | -298.4% |
| EPS | -0.7 | -0.54 | -2.05 | -2.36 |
| % Growth | -29.6% | 73.7% | 13.1% | – |
| EPS Diluted | -0.7 | -0.54 | -2.05 | -2.36 |
| Weighted Avg Shares Out | 138,277 | 106,097 | 78,856 | 51,826 |
| Weighted Avg Shares Out Dil | 138,277 | 106,097 | 78,856 | 51,826 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $30 |
| Interest Expense | $0 | $0 | $0 | – |
| Depreciation & Amortization | $8,663 | $9,206 | $10,114 | $9,835 |
| EBITDA | -$101,740 | -$58,790 | -$152,606 | -$117,181 |
| % Margin | -93.9% | -51.9% | -4,182.1% | -286.1% |